Seek Returns logo

RVTY vs. THC: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at RVTY and THC, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolRVTYTHC
Company NameRevvity, Inc.Tenet Healthcare Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Providers & Services
Market Capitalization10.65 billion USD17.85 billion USD
ExchangeNYSENYSE
Listing DateFebruary 21, 1973March 17, 1980
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of RVTY and THC by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

RVTY vs. THC: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolRVTYTHC
5-Day Price Return3.74%3.26%
13-Week Price Return-9.38%15.36%
26-Week Price Return-18.36%52.62%
52-Week Price Return-30.47%24.40%
Month-to-Date Return-2.73%10.15%
Year-to-Date Return-21.47%60.85%
10-Day Avg. Volume1.32M1.17M
3-Month Avg. Volume1.25M1.43M
3-Month Volatility40.14%35.98%
Beta1.011.54

Profitability

Return on Equity (TTM)

RVTY

3.71%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.51%
Median
6.47%
Q1
3.86%
Min
-6.95%

RVTY’s Return on Equity of 3.71% is in the lower quartile for the Life Sciences Tools & Services industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.

THC

37.25%

Health Care Providers & Services Industry

Max
24.86%
Q3
15.79%
Median
8.56%
Q1
5.75%
Min
-1.64%

THC’s Return on Equity of 37.25% is exceptionally high, placing it well beyond the typical range for the Health Care Providers & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

RVTY vs. THC: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Net Profit Margin (TTM)

RVTY

10.19%

Life Sciences Tools & Services Industry

Max
32.18%
Q3
18.30%
Median
10.19%
Q1
4.20%
Min
-2.05%

RVTY’s Net Profit Margin of 10.19% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

THC

7.17%

Health Care Providers & Services Industry

Max
11.56%
Q3
5.45%
Median
2.83%
Q1
1.13%
Min
-1.71%

A Net Profit Margin of 7.17% places THC in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.

RVTY vs. THC: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Operating Profit Margin (TTM)

RVTY

13.57%

Life Sciences Tools & Services Industry

Max
38.39%
Q3
21.40%
Median
13.57%
Q1
8.38%
Min
-3.51%

RVTY’s Operating Profit Margin of 13.57% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

THC

17.77%

Health Care Providers & Services Industry

Max
19.08%
Q3
9.66%
Median
4.77%
Q1
2.46%
Min
-0.83%

An Operating Profit Margin of 17.77% places THC in the upper quartile for the Health Care Providers & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

RVTY vs. THC: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Profitability at a Glance

SymbolRVTYTHC
Return on Equity (TTM)3.71%37.25%
Return on Assets (TTM)2.29%5.11%
Net Profit Margin (TTM)10.19%7.17%
Operating Profit Margin (TTM)13.57%17.77%
Gross Profit Margin (TTM)55.93%82.36%

Financial Strength

Current Ratio (MRQ)

RVTY

3.33

Life Sciences Tools & Services Industry

Max
3.46
Q3
2.78
Median
1.91
Q1
1.53
Min
0.43

RVTY’s Current Ratio of 3.33 is in the upper quartile for the Life Sciences Tools & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

THC

1.71

Health Care Providers & Services Industry

Max
2.00
Q3
1.51
Median
1.29
Q1
0.92
Min
0.14

THC’s Current Ratio of 1.71 is in the upper quartile for the Health Care Providers & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

RVTY vs. THC: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

RVTY

0.43

Life Sciences Tools & Services Industry

Max
1.35
Q3
0.74
Median
0.41
Q1
0.18
Min
0.00

RVTY’s Debt-to-Equity Ratio of 0.43 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

THC

3.51

Health Care Providers & Services Industry

Max
2.29
Q3
1.24
Median
0.74
Q1
0.50
Min
0.00

With a Debt-to-Equity Ratio of 3.51, THC operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

RVTY vs. THC: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Interest Coverage Ratio (TTM)

RVTY

15.30

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

RVTY’s Interest Coverage Ratio of 15.30 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

THC

10.27

Health Care Providers & Services Industry

Max
14.47
Q3
7.50
Median
4.52
Q1
2.12
Min
-4.44

THC’s Interest Coverage Ratio of 10.27 is in the upper quartile for the Health Care Providers & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

RVTY vs. THC: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Financial Strength at a Glance

SymbolRVTYTHC
Current Ratio (MRQ)3.331.71
Quick Ratio (MRQ)2.751.54
Debt-to-Equity Ratio (MRQ)0.433.51
Interest Coverage Ratio (TTM)15.3010.27

Growth

Revenue Growth

RVTY vs. THC: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

RVTY vs. THC: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

RVTY

0.32%

Life Sciences Tools & Services Industry

Max
1.41%
Q3
0.65%
Median
0.35%
Q1
0.00%
Min
0.00%

RVTY’s Dividend Yield of 0.32% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

THC

0.00%

Health Care Providers & Services Industry

Max
5.93%
Q3
2.59%
Median
1.35%
Q1
0.00%
Min
0.00%

THC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

RVTY vs. THC: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Dividend Payout Ratio (TTM)

RVTY

11.88%

Life Sciences Tools & Services Industry

Max
113.14%
Q3
61.34%
Median
17.74%
Q1
0.00%
Min
0.00%

RVTY’s Dividend Payout Ratio of 11.88% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

THC

0.00%

Health Care Providers & Services Industry

Max
185.33%
Q3
74.82%
Median
36.00%
Q1
0.00%
Min
0.00%

THC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

RVTY vs. THC: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Dividend at a Glance

SymbolRVTYTHC
Dividend Yield (TTM)0.32%0.00%
Dividend Payout Ratio (TTM)11.88%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

RVTY

36.78

Life Sciences Tools & Services Industry

Max
75.35
Q3
51.00
Median
32.93
Q1
25.27
Min
1.43

RVTY’s P/E Ratio of 36.78 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

THC

11.92

Health Care Providers & Services Industry

Max
40.02
Q3
29.75
Median
21.09
Q1
14.18
Min
7.05

In the lower quartile for the Health Care Providers & Services industry, THC’s P/E Ratio of 11.92 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

RVTY vs. THC: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

RVTY

3.75

Life Sciences Tools & Services Industry

Max
10.49
Q3
6.43
Median
4.66
Q1
2.88
Min
1.08

RVTY’s P/S Ratio of 3.75 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

THC

0.86

Health Care Providers & Services Industry

Max
3.15
Q3
1.87
Median
0.74
Q1
0.27
Min
0.09

THC’s P/S Ratio of 0.86 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

RVTY vs. THC: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

RVTY

1.51

Life Sciences Tools & Services Industry

Max
6.69
Q3
5.00
Median
3.46
Q1
2.38
Min
0.93

RVTY’s P/B Ratio of 1.51 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

THC

4.36

Health Care Providers & Services Industry

Max
7.33
Q3
4.45
Median
2.52
Q1
1.15
Min
0.66

THC’s P/B Ratio of 4.36 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

RVTY vs. THC: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Providers & Services industry benchmarks.

Valuation at a Glance

SymbolRVTYTHC
Price-to-Earnings Ratio (TTM)36.7811.92
Price-to-Sales Ratio (TTM)3.750.86
Price-to-Book Ratio (MRQ)1.514.36
Price-to-Free Cash Flow Ratio (TTM)20.857.99